Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Free Cash Flow (2016 - 2025)

Rockwell Medical (RMTI) has disclosed Free Cash Flow for 16 consecutive years, with -$1.5 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Free Cash Flow fell 137.61% year-over-year to -$1.5 million, compared with a TTM value of -$2.9 million through Sep 2025, down 211.42%, and an annual FY2024 reading of $3.2 million, up 132.91% over the prior year.
  • Free Cash Flow was -$1.5 million for Q3 2025 at Rockwell Medical, down from $1.7 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at $4.1 million in Q3 2024 and bottomed at -$12.5 million in Q1 2021.
  • Average Free Cash Flow over 5 years is -$3.2 million, with a median of -$2.5 million recorded in 2024.
  • The sharpest move saw Free Cash Flow plummeted 268.79% in 2023, then skyrocketed 646.51% in 2024.
  • Year by year, Free Cash Flow stood at -$9.1 million in 2021, then skyrocketed by 95.7% to -$393000.0 in 2022, then soared by 78.12% to -$86000.0 in 2023, then surged by 646.51% to $470000.0 in 2024, then tumbled by 426.81% to -$1.5 million in 2025.
  • Business Quant data shows Free Cash Flow for RMTI at -$1.5 million in Q3 2025, $1.7 million in Q2 2025, and -$3.6 million in Q1 2025.